165 related articles for article (PubMed ID: 11677136)
1. 3-Aryl-4-aryloyl-1-(1H-imidazol-5-yl)methylpyrrole, a novel class of farnesyltransferase inhibitors.
Lee H; Lee J; Shin Y; Jung W; Kim JH; Park K; Ro S; Chung HH; Koh JS
Bioorg Med Chem Lett; 2001 Nov; 11(22):2963-5. PubMed ID: 11677136
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of 4-[(3-methyl-3H-imidazol-4-yl)-(2-phenylethynyl-benzyloxy)-methyl]-benzonitrile as novel farnesyltransferase inhibitor.
Lin NH; Wang L; Cohen J; Gu WZ; Frost D; Zhang H; Rosenberg S; Sham H
Bioorg Med Chem Lett; 2003 Nov; 13(21):3821-5. PubMed ID: 14552788
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of 4-[3-biphenyl-2-yl-1-hydroxy-1-(3-methyl-3H-imidazol-4-yl)-prop-2-ynyl]-1-yl-benzonitrile as novel farnesyltransferase inhibitor.
Lin NH; Wang L; Cohen J; Gu WZ; Frost D; Zhang H; Rosenberg S; Sham H
Bioorg Med Chem Lett; 2003 Apr; 13(7):1293-6. PubMed ID: 12657267
[TBL] [Abstract][Full Text] [Related]
4. Discovery of potent imidazole and cyanophenyl containing farnesyltransferase inhibitors with improved oral bioavailability.
Tong Y; Lin NH; Wang L; Hasvold L; Wang W; Leonard N; Li T; Li Q; Cohen J; Gu WZ; Zhang H; Stoll V; Bauch J; Marsh K; Rosenberg SH; Sham HL
Bioorg Med Chem Lett; 2003 May; 13(9):1571-4. PubMed ID: 12699757
[TBL] [Abstract][Full Text] [Related]
5. A novel class of highly potent, selective, and non-peptidic inhibitor of Ras farnesyltransferase (FTase).
Lee H; Lee J; Lee S; Shin Y; Jung W; Kim JH; Park K; Kim K; Cho HS; Ro S; Lee S; Jeong SW; Choi T; Chung HH; Koh JS
Bioorg Med Chem Lett; 2001 Dec; 11(23):3069-72. PubMed ID: 11714612
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of 1-benzyl-5-(3-biphenyl-2-yl-propyl)-1H-imidazole as novel farnesyltransferase inhibitor.
Lin NH; Wang L; Wang X; Wang GT; Cohen J; Gu WZ; Zhang H; Rosenberg SH; Sham HL
Bioorg Med Chem Lett; 2004 Oct; 14(20):5057-62. PubMed ID: 15380198
[TBL] [Abstract][Full Text] [Related]
7. 7-imidazolylalkanamido-1-carboxylalkylbenzo-diazepine, a novel series of farnesyltransferase inhibitors.
Wan SB; Chu FM; Guo ZR
Yao Xue Xue Bao; 2002 Jul; 37(7):516-21. PubMed ID: 12914320
[TBL] [Abstract][Full Text] [Related]
8. Peptidomimetic inhibitors of protein farnesyltransferase show potent antimalarial activity.
Ohkanda J; Lockman JW; Yokoyama K; Gelb MH; Croft SL; Kendrick H; Harrell MI; Feagin JE; Blaskovich MA; Sebti SM; Hamilton AD
Bioorg Med Chem Lett; 2001 Mar; 11(6):761-4. PubMed ID: 11277514
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and biological activity of 4-[(4-cyano-2-arylbenzyloxy)-(3-methyl-3H-imidazol-4-yl)methyl]benzonitriles as potent and selective farnesyltransferase inhibitors.
Wang L; Wang GT; Wang X; Tong Y; Sullivan G; Park D; Leonard NM; Li Q; Cohen J; Gu WZ; Zhang H; Bauch JL; Jakob CG; Hutchins CW; Stoll VS; Marsh K; Rosenberg SH; Sham HL; Lin NH
J Med Chem; 2004 Jan; 47(3):612-26. PubMed ID: 14736242
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of conformationally constrained 5,6,7, 8-Tetrahydroimidazo[1,5-a]pyridine inhibitors of farnesyltransferase.
Dinsmore CJ; Zartman CB; Baginsky WF; O'Neill TJ; Koblan KS; Chen IW; McLoughlin DA; Olah TV; Huff JR
Org Lett; 2000 Nov; 2(22):3473-6. PubMed ID: 11082012
[TBL] [Abstract][Full Text] [Related]
11. Discovery of (R)-7-cyano-2,3,4, 5-tetrahydro-1-(1H-imidazol-4-ylmethyl)-3- (phenylmethyl)-4-(2-thienylsulfonyl)-1H-1,4-benzodiazepine (BMS-214662), a farnesyltransferase inhibitor with potent preclinical antitumor activity.
Hunt JT; Ding CZ; Batorsky R; Bednarz M; Bhide R; Cho Y; Chong S; Chao S; Gullo-Brown J; Guo P; Kim SH; Lee FY; Leftheris K; Miller A; Mitt T; Patel M; Penhallow BA; Ricca C; Rose WC; Schmidt R; Slusarchyk WA; Vite G; Manne V
J Med Chem; 2000 Oct; 43(20):3587-95. PubMed ID: 11020273
[TBL] [Abstract][Full Text] [Related]
12. 3-Imidazolylmethylaminophenylsulfonyltetrahydroquinolines, a novel series of farnesyltransferase inhibitors.
Ding CZ; Hunt JT; Ricca C; Manne V
Bioorg Med Chem Lett; 2000 Feb; 10(3):273-5. PubMed ID: 10698452
[TBL] [Abstract][Full Text] [Related]
13. Discovery and structure-activity relationships of imidazole-containing tetrahydrobenzodiazepine inhibitors of farnesyltransferase.
Ding CZ; Batorsky R; Bhide R; Chao HJ; Cho Y; Chong S; Gullo-Brown J; Guo P; Kim SH; Lee F; Leftheris K; Miller A; Mitt T; Patel M; Penhallow BA; Ricca C; Rose WC; Schmidt R; Slusarchyk WA; Vite G; Yan N; Manne V; Hunt JT
J Med Chem; 1999 Dec; 42(25):5241-53. PubMed ID: 10602709
[TBL] [Abstract][Full Text] [Related]
14. Design and biological activity of (S)-4-(5-([1-(3-chlorobenzyl)-2-oxopyrrolidin-3-ylamino]methyl)imidazol-1-ylmethyl)benzonitrile, a 3-aminopyrrolidinone farnesyltransferase inhibitor with excellent cell potency.
Bell IM; Gallicchio SN; Abrams M; Beshore DC; Buser CA; Culberson JC; Davide J; Ellis-Hutchings M; Fernandes C; Gibbs JB; Graham SL; Hartman GD; Heimbrook DC; Homnick CF; Huff JR; Kassahun K; Koblan KS; Kohl NE; Lobell RB; Lynch JJ; Miller PA; Omer CA; Rodrigues AD; Walsh ES; Williams TM
J Med Chem; 2001 Aug; 44(18):2933-49. PubMed ID: 11520202
[TBL] [Abstract][Full Text] [Related]
15. Non-thiol farnesyltransferase inhibitors: N-(4-Acylamino-3-benzoylphenyl)-4-nitrocinnamic acid amides.
Sakowski J; Sattler I; Schlitzer M
Bioorg Med Chem; 2002 Feb; 10(2):233-9. PubMed ID: 11741771
[TBL] [Abstract][Full Text] [Related]
16. N-arylpiperazinone inhibitors of farnesyltransferase: discovery and biological activity.
Williams TM; Bergman JM; Brashear K; Breslin MJ; Dinsmore CJ; Hutchinson JH; MacTough SC; Stump CA; Wei DD; Zartman CB; Bogusky MJ; Culberson JC; Buser-Doepner C; Davide J; Greenberg IB; Hamilton KA; Koblan KS; Kohl NE; Liu D; Lobell RB; Mosser SD; O'Neill TJ; Rands E; Schaber MD; Huff JR
J Med Chem; 1999 Sep; 42(19):3779-84. PubMed ID: 10508426
[No Abstract] [Full Text] [Related]
17. Non-thiol farnesyltransferase inhibitors: FTase-inhibition and cellular activity of benzophenone-based bisubstrate analogue farnesyltransferase inhibitors.
Mitsch A; Bergemann S; Gust R; Sattler I; Schlitzer M
Arch Pharm (Weinheim); 2003 Jul; 336(4-5):242-50. PubMed ID: 12916059
[TBL] [Abstract][Full Text] [Related]
18. Aryloxy substituted N-arylpiperazinones as dual inhibitors of farnesyltransferase and geranylgeranyltransferase-I.
Bergman JM; Abrams MT; Davide JP; Greenberg IB; Robinson RG; Buser CA; Huber HE; Koblan KS; Kohl NE; Lobell RB; Graham SL; Hartman GD; Williams TM; Dinsmore CJ
Bioorg Med Chem Lett; 2001 Jun; 11(11):1411-5. PubMed ID: 11378366
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of potential bisubstrate inhibitors of protein farnesyltransferase. Design and synthesis of functionalized imidazoles.
de Figueiredo RM; Coudray L; Dubois J
Org Biomol Chem; 2007 Oct; 5(20):3299-309. PubMed ID: 17912382
[TBL] [Abstract][Full Text] [Related]
20. Non-thiol farnesyltransferase inhibitors: utilization of the far aryl binding site by 5-cinnamoylaminobenzophenones.
Mitsch A; Wissner P; Böhm M; Silber K; Klebe G; Sattler I; Schlitzer M
Arch Pharm (Weinheim); 2004 Sep; 337(9):493-501. PubMed ID: 15362122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
